Peter Fransen

Peter Fransen

Auto-generated profile, based on publicly available information

Peter Fransen

Institute for Complex Molecular Systems, Eindhoven University of Technology

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2011 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
TAThomas Ameringer
Thomas Ameringer
PFPeter Fransen
Peter Fransen
PBPenny Bean
Penny Bean
GJGraham Johnson
Graham Johnson
SPSuzanne Pereira
Suzanne Pereira
LMLaurence Meagher
Laurence Meagher

1 October 2014 in Acta Biomaterialia
Verified
Journal Article
Open access
RSRyan J. Seelbach
Ryan J. Seelbach
PFPeter Fransen
Peter Fransen
MPMarianna Peroglio
Marianna Peroglio
DMDaniel Pulido Martinez
Daniel Pulido Martinez
PCPatricia Lopez Chicon
Patricia Lopez Chicon
DEDavid Eglin
David Eglin
The controlled presentation of biofunctionality is of key importance for hydrogel applications in cell-based regenerative medicine. Here, a versatile approach was demonstrated to present clustered binding epitopes in an injectable, thermoresponsive hydrogel. Well-defined multivalent dendrimers bearing four integrin binding sequences and an azido moiety were covalently grafted to propargylamine-derived hyaluronic acid (Hyal-pa) using copper-catalyzed alkyne-azide cycloaddition (CuAAC), and then combined with pN-modified hyaluronan (Hyal-pN). The dendrimers were prepared by synthesizing a bifunctional diethylenetriamine pentaacetic acid core with azido and NHBoc oligo(ethylene glycol) aminoethyl branches, then further conjugated with solid-phase synthesized RGDS and DGRS peptides. Azido terminated pN was synthesized by reversible addition-fragmentation chain transfer polymerization and reacted to Hyal-pa via CuAAC. Nuclear magnetic resonance (NMR), high performance liquid chromatography, size exclusion chromatography and mass spectroscopy proved that the dendrimers had well-defined size and were disubstituted. NMR and atomic absorption analysis confirmed the hyaluronan was affixed with dendrimers or pN. Rheological measurements demonstrated that dendrimers do not influence the elastic or viscous moduli of thermoresponsive hyaluronan compositions at a relevant biological concentration. Finally, human mesenchymal stromal cells were encapsulated in the biomaterial and cultured for 21days, demonstrating the faculty of this dendrimer-modified hydrogel as a molecular toolbox for tailoring the biofunctionality of thermoresponsive hyaluronan carriers for biomedical applications.

3 November 2015 in Synlett
Verified
Journal Article
Closed access
PDF file
Patricia DankersPatricia Dankers
Patricia Dankers
IFIsja de Feijter
Isja de Feijter
OGOlga J. G. M. Goor
Olga J. G. M. Goor
SHSimone I. S. Hendrikse
Simone I. S. Hendrikse
MCMarta Comellas-Aragonès
Marta Comellas-Aragonès
LMLech-Gustav Milroy
Lech-Gustav Milroy
Supramolecular polymers have shown to be powerful scaffolds for tissue engineering applications. Supramolecular biomaterials functionalized with ureidopyrimidinone (UPy) moieties, which dimerize via quadruple hydrogen-bond formation, are eminently suitable for this purpose. The conjugation of the UPy moiety to biologically active peptides ensures adequate integration into the supramolecular UPy polymer matrix. The structural complexity of UPy–peptide conjugates makes their synthesis challenging and until recently low yielding, thus restricted the access to structurally diverse derivatives. Here we report optimization studies of a convergent solid-phase based synthesis of UPy-modified peptides. The peptide moiety is synthesized using standard Fmoc solid-phase synthesis and the UPy fragment is introduced on the solid-phase simplifying the synthesis and purification of the final UPy–peptide conjugate. The convergent nature of the synthesis reduces the number of synthetic steps in the longest linear sequence compared to other synthetic approaches. We demonstrate the utility of the optimized route by synthesizing a diverse range of biologically active UPy–peptide bioconjugates in multimilligram scale for diverse biomaterial applications. 1 Introduction 2 Divergent Synthesis 3 Convergent Synthesis 4 UPy–Amine Strategy 5 UPy–Carboxylic Acid Strategy 6 Conclusion